RACGP rejects proposed cuts to surgical assistance fees The RACGP has questioned suggested changes to surgical assistance MBS items that would effectively cut payments by a quarter.
Do we need to reassess the flu vaccine? Dr Evan Ackermann looks at recent research on the use of the flu vaccine in Australia.
Medicare freeze continues to thaw – but not fast enough, RACGP says The indexation of consultation items is not high enough to cover the true costs or value of general practice care.
Changes to MBS items for knee imaging: What GPs should know Associate Professor Mark Morgan, GP and member of the Diagnostic Medicine Clinical Committee of the Medicare Benefits Schedule Review Taskforce, writes for newsGP about changes to MBS items for knee imaging.
Budget leaves room for improvement in general practice, GP says The Government has committed to meeting the needs of rural and older Australians in the Federal Budget, but there is still much room for improvement in general practice, Dr Edwin Kruys writes.
Government ignores recommendations from pharmacy review The RACGP is disappointed at the ‘squandered opportunity’ for the Federal Government to make necessary reforms to the pharmacy sector.
RACGP calls for better support for GPs providing aged care services GPs’ central role in the care of older Australians is being compromised by a lack of proper support and resources, according to the RACGP’s submission to the Department of Health’s Aged Care Workforce Strategy Taskforce.
What the new after-hours rebates mean for GPs The Federal Government’s recent changes to Medicare rebates are designed to better reflect the qualifications of doctors providing urgent after-hours care.
RACGP welcomes changes to after-hours care rebates President Dr Bastian Seidel has applauded Federal Minister for Health Greg Hunt for heeding the RACGP’s concerns and implementing evidence-based adjustments to after-hours Medicare rebates.
After-hours care not value for money The current structure of after-hours healthcare provision in Australia ‘supports the provision of comparatively low-value medical care and does not represent value for money for the taxpayer’, the Medicare Benefits Schedule (MBS) Review Taskforce has found in its final report.